Internal Med Medical News about Cardiovascular Diseases Cholesterol, HDL Cholesterol, LDL Risk Triglycerides

Become a Member Today!
Register

Most Viewed Abstracts

1. Report Shows Shift in Starting Salaries for Physicians

2. Recommendations on the use of 18F-FDG PET in oncology

3. Gene expression signatures, clinicopathological features, and individualized therapy in breast cancer

4. AHA Guidelines on Cardiac CT for Assessing Coronary Artery Disease

5. Rapid correction of low vitamin D status in nursing home residents

Your Article Summary

See Latest Articles

(Click the title below to leave the MDLinx Network and go to the Journal's Website)

Thinking beyond low-density lipoprotein cholesterol: strategies to further reduce cardiovascular risk
Vascular Health and Risk Management, 09/22/09

Some trials have highlighted the significance of residual cardiovascular risk after treatment of LDL–C to target levels. This residual risk is partially due to low HDL–C and high triglycerides (TG) despite achievement of LDL goals with statin therapy. The NCEP ATP III guidelines reported that low HDL–C is a significant and an independent risk factor for coronary heart disease (CHD) and is inversely related to CHD. Epidemiologic studies have also shown a similar inverse relationship of HDL–C with CHD. High–density lipoprotein cholesterol (HDL–C) may directly participate in the anti–atherogenic process by promoting efflux of cholesterol of the foam cells of atherogenic lesions. Many studies have demonstrated multiple anti–atherogenic actions of HDL–C and its role in promoting efflux of cholesterol from the foam cells. The residual risk by increased TG with or without low HDL–C can be assessed by calculating non–HDL–C and a reduction in TG results in decreased CHD.

<< Previous
Putting The Public's Money Where Its Mouth Is

Next >>
The effectiveness and retention rates of methotrexate in...

Rosuvastatin along the cardiovascular continuum: from JUPITER to AURORA
Expert Review of Cardiovascular Therapy, 11/16/09 Relevance Score: 99%

Reduction of Skeletal Muscle, Especially in Lower Limbs, in Japanese Type 2 Diabetic Patients With Insulin Resistance and Cardiovascular Risk Factors
Metabolic Syndrome and Related Disorders, 11/11/09 Relevance Score: 97%

The value of drugs for obesity in the management of cardiovascular risk factors
Sang Thrombose Vaisseaux, 11/04/09 Relevance Score: 97%

Review of extended-release niacin/laropiprant fixed combination in the treatment of mixed dyslipidemia and primary hypercholesterolemia
Vascular Health and Risk Management, 11/03/09 Relevance Score: 97%

Reference Values for 27 Clinical Chemistry Tests in 70-Year-Old Males and Females
Gerontology, 10/21/09 Relevance Score: 97%